Leerink Partners Downgrades Imprivata (IMPR) to Market Perform; Doesn't See Cerner (CERN) Making Competing Bid
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Stifel Downgrades Imprivata (IMPR) to Hold
July 13, 2016 1:58 PM EDTStifel downgraded Imprivata (NYSE: IMPR) from Buy to Hold and removed its price target (prior $20.00).
For an analyst ratings summary and ratings history on Imprivata click here. For more ratings news on Imprivata click here.
Shares of Imprivata closed at $14.50 yesterday.
... MorePiper Jaffray Downgrades Imprivata (IMPR) to Neutral
July 13, 2016 12:51 PM EDTPiper Jaffray downgraded Imprivata (NYSE: IMPR) from Overweight to Neutral.
For an analyst ratings summary and ratings history on Imprivata click here. For more ratings news on Imprivata click here.
Shares of Imprivata closed at $14.50 yesterday.
... MoreThoma Bravo to Acquire Imprivata (IMPR) for $544M
July 13, 2016 8:01 AM EDTImprivata (NYSE: IMPR) entered into a definitive agreement to be acquired by an affiliate of Thoma Bravo, LLC, a leading private equity investment firm. Under the terms of the agreement, shareholders of record will receive $19.25 in cash per share of Imprivata common stock, which represents a 33% premium to Imprivatas last closing stock price of $14.50. The value of the transaction is approximately $544 million.
Were tremendously excited about Thoma Bravos investment in our company and believe this... More
